Jennifer Gabler

Jennifer Gabler is an experienced financial professional with a strong background in the biotechnology and startup sectors. She currently serves as the Chief Financial Officer (CFO) at EvolveImmune Therapeutics.2 With over 25 years of experience as a CFO for venture-backed and startup companies, Jennifer has developed expertise in financial governance, strategic planning, risk management, and performance optimization.1

Prior to her current role, Jennifer worked as a Finance Consultant at Allyx Therapeutics.3 She has also held positions at other companies, including:

1. Partner at Marlborough Street Partners3
2. CFO at Extraprise (now Vericast), a marketing services company1

Jennifer's educational background includes:

• MBA in Finance from Columbia Business School24
• Certified Public Accountant (CPA) certification4

Throughout her career, Jennifer has focused on translating complex financial information for various stakeholders and providing financial leadership to growing companies.4 Her LinkedIn profile can be found under the username jennifergabler1.2